Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-10 in Atopic Dermatitis
NCT00690807Phase 2Completed
- Sponsor
- Provectus Biopharmaceuticals
- Start
- Jun 2008
- Primary completion
- Aug 2009
- Modality
- Hydrogel Systems, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PH-10 in atopic dermatitis (AD), sponsored by Provectus Biopharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
PH-10
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00690807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690807.